These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2867493)

  • 1. [A beta blockader-diuretic combination in long-term anti-hypertensive therapy. Undesirable effects on blood potassium].
    Severin E; Mladovan G
    Minerva Cardioangiol; 1985 Oct; 33(10):635-7. PubMed ID: 2867493
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypokalemic rhabdomyolysis associated with diuretic and beta blockader therapy].
    Acquarone N; Vinciguerra G; Crisalli MP
    Recenti Prog Med; 1987 Jan; 78(1):33-5. PubMed ID: 3589118
    [No Abstract]   [Full Text] [Related]  

  • 3. Potassium loss associated with hydrochlorothiazide versus chlorthalidone.
    Sumiye L; Vivian AS; Frisof KB; Podany EC
    Clin Ther; 1981; 4(4):308-20. PubMed ID: 7332917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypokalemia during the treatment of arterial hypertension with diuretics.
    Lemieux G; Beauchemin M; Vinay P; Gougoux A
    Can Med Assoc J; 1980 Apr; 122(8):905-7. PubMed ID: 7370875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.
    Channick BJ; Kessler WB; Marks AD; Adlin EV
    Clin Ther; 1981; 4(3):175-83. PubMed ID: 7307035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hypertension with a fixed combination of bopindolol and chlorthalidone (Sandoretic)].
    Widimský J; Lánská V; Hulínský V; Balazovjech I; Havlík V; Havránek P; Kroupa E; Nikodýmová L; Pátek F; Svítil F; Svihovcová P
    Vnitr Lek; 1996 Apr; 42(4):223-8. PubMed ID: 8693706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretic induced hypokalemia in the elderly.
    Navarro RP; O'Brien DK; Nuffort P; Spencer DL
    J Fam Pract; 1982 Apr; 14(4):685-9. PubMed ID: 7069387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diuretic-induced hypokalemia and altered renal function.
    Carney SL; Morgan TO
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):665-7. PubMed ID: 3546168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aldosteronism after hypokalemia in diuretic therapy of systemic arterial hypertension].
    Sánchez Torres G; Posadas C; Olvera S; Serrano P
    Arch Inst Cardiol Mex; 1978; 48(4):853-70. PubMed ID: 697472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonarrhythmogenicity of diuretic-induced hypokalemia. Its evidence in patients with uncomplicated hypertension.
    Madias JE; Madias NE; Gavras HP
    Arch Intern Med; 1984 Nov; 144(11):2171-6. PubMed ID: 6497518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E; Anson O; Neumann L
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium and diuretic-induced ventricular arrhythmias in ambulatory hypertensive patients.
    Caralis PV; Materson BJ; Perez-Stable E
    Miner Electrolyte Metab; 1984; 10(3):148-54. PubMed ID: 6727801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy.
    Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the administration time on the antihypertensive and hypokalaemic effects of chlorthalidone in patients with primary hypertension.
    Carpentiere G; Marino S; Castello F
    Int J Clin Pharmacol Res; 1985; 5(2):109-12. PubMed ID: 3894256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of hypokalemia in the diuretic treatment of hypertensives].
    Laplante L
    Union Med Can; 1985 Mar; 114(3):207-11. PubMed ID: 4002433
    [No Abstract]   [Full Text] [Related]  

  • 19. Managing diuretic-induced hypokalemia in ambulatory hypertensive patients.
    Fischer RG
    J Fam Pract; 1982 Jun; 14(6):1029-36. PubMed ID: 7045273
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of hydrochlorothiazide in hypertensive patients and the need for potassium supplementation.
    Kochar MS; Itskovitz HD
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):298-304. PubMed ID: 4197254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.